Sanofi Consumer Healthcare India Limited has officially appointed Price Waterhouse & Co Chartered Accountants LLP as its new Statutory Auditor. This appointment follows the recent resignation of the company’s previous auditors. The new firm will serve an initial term filling the casual vacancy until the upcoming Annual General Meeting and has also been approved for a subsequent five-year tenure, concluding in 2031, subject to final shareholder approval.
Auditor Transition
Following the resignation of M/s. Kalyaniwalla & Mistry LLP, Sanofi Consumer Healthcare India Limited has named Price Waterhouse & Co Chartered Accountants LLP as the successor for the role of Statutory Auditor. The board finalized this decision during a meeting held on May 25, 2026, based on the recommendation of the audit committee.
Terms of Appointment
The appointment process is divided into two distinct phases. Initially, the new firm will hold office to fill the casual vacancy created by the predecessor’s departure, effective from May 25, 2026, until the conclusion of the company’s next Annual General Meeting. Subsequently, the Board of Directors has approved a long-term engagement for five consecutive years. This extended term will commence following the 2026 meeting and will continue through to the conclusion of the company’s eighth Annual General Meeting in 2031.
About the New Statutory Auditor
The newly appointed firm is a reputable member of the Price Waterhouse & Affiliates network, with a history dating back to 1991 and a conversion into a limited liability partnership in 2014. Headquartered in Kolkata, the firm maintains 17 branch offices across India and employs over 120 assurance partners. Their appointment brings extensive experience in auditing publicly listed companies to the organization.
Source: BSE
